Terms: = Germ cell tumor AND FAS, FAS1, 355, ENSG00000026103, FASTM, APO-1, P25445, CD95, ALPS1A, TNFRSF6, APT1 AND Staging
6 results:
1. [Analysis of clinicopathological characteristics, therapeutic strategy and prognosis of 501 patients with gastric neuroendocrine neoplasms attending a single center].
Zhang BL; Lu YX; Liang WQ; Gao YH; Xi HQ; Wang XX; Zhang KC; Chen L
Zhonghua Wei Chang Wai Ke Za Zhi; 2023 May; 26(5):459-466. PubMed ID: 37217354
[No Abstract] [Full Text] [Related]
2. [Pathological characteristics and survival analysis of 355 patients with gastroenteropancreatic neuroendocrine neoplasms].
Li Y; Wang YF; Tan BB; Er LM; Zhao Q; Fan LQ; Zhang ZD; Liu Y
Zhonghua Zhong Liu Za Zhi; 2020 May; 42(5):426-431. PubMed ID: 32482035
[No Abstract] [Full Text] [Related]
3. B7-H abnormalities in melanoma and clinical relevance.
Seliger B
Methods Mol Biol; 2014; 1102():367-80. PubMed ID: 24258988
[TBL] [Abstract] [Full Text] [Related]
4. miR-106a-5p inhibits the proliferation and migration of astrocytoma cells and promotes apoptosis by targeting fasTK.
Zhi F; Zhou G; Shao N; Xia X; Shi Y; Wang Q; Zhang Y; Wang R; Xue L; Wang S; Wu S; Peng Y; Yang Y
PLoS One; 2013; 8(8):e72390. PubMed ID: 24013584
[TBL] [Abstract] [Full Text] [Related]
5. Serum microRNAs as biomarkers for recurrence in melanoma.
Friedman EB; Shang S; de Miera EV; Fog JU; Teilum MW; Ma MW; Berman RS; Shapiro RL; Pavlick AC; Hernando E; Baker A; Shao Y; Osman I
J Transl Med; 2012 Aug; 10():155. PubMed ID: 22857597
[TBL] [Abstract] [Full Text] [Related]
6. Prognostic significance of soluble fas and soluble fas ligand in serum of patients with complete hydatidiform moles.
Soni S; Rath G; Deval R; Salhan S; Mishra AK; Saxena S
Am J Reprod Immunol; 2011 Sep; 66(3):230-6. PubMed ID: 21385271
[TBL] [Abstract] [Full Text] [Related]